Fmr Llc

13F Holdings History for Vaxcyte, Inc. - COMMON STOCK (PCVX)

Symbol: PCVX on Nasdaq
Investment type: Equity / COMMON STOCK
Latest Disclosed Ownership: 13.1M shares
Security Ownership: 10.1%

Shares, Excluding Options vs Price

Value, Excluding Options

FMR LLC ownership in Vaxcyte, Inc. COMMON STOCK (PCVX)

2025-09-08 - FMR LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 13.1M shares of Vaxcyte, Inc. COMMON STOCK (PCVX). This represents 10.1% percent ownership of the company. In their previous filing dated 2025-08-06, FMR LLC had reported owning 12.1M shares, indicating an increase of 8.5% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
FMR LLC	10.1%	+7.78%	$414M	13.1M	+1,028,776	+8.5%	$31.55	13G/A	8/29/2025	8 Sep 2025 11:46:16
FMR LLC	9.4%	-10%	$351M	12.1M	-950,095	-7.28%	$29.00	13G/A	6/30/2025	6 Aug 2025 12:19:41
FMR LLC	10.5%		$366M	13.1M			$28.04	13G/A	12/31/2024	12 Feb 2025 09:34:20

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2025	0.02%	+0%	$451M	12.5M	+358,883	+2.95%	$36.02	Q3 2025
6/30/2025	0.02%	0%	$395M	12.2M	-361,184	-2.89%	$32.51	Q2 2025
3/31/2025	0.03%	0%	$472M	12.5M	-579,414		$37.76	Q1 2025
12/31/2024	0.06%	-0.01%	$1.07B	13.1M	-2,709,019	-17.1%	$81.86	Q4 2024
9/30/2024	0.11%	0%	$1.81B	15.8M	-366,673	-2.27%	$114.27	Q3 2024
6/30/2024	0.08%	0%	$1.22B	16.2M	-93,819	-0.58%	$75.51	Q2 2024
3/31/2024	0.07%	+0.01%	$1.11B	16.3M	+2,047,794	+14.4%	$68.31	Q1 2024
12/31/2023	0.07%	+0%	$893M	14.2M	+136,328	+0.97%	$62.80	Q4 2023
9/30/2023	0.06%	+0%	$718M	14.1M	+20,801	+0.15%	$50.98	Q3 2023
6/30/2023	0.06%	+0.01%	$702M	14.1M	+2,247,671	+19%	$49.94	Q2 2023
3/31/2023	0.04%	+0.01%	$443M	11.8M	+1,639,283	+16.1%	$37.48	Q1 2023
12/31/2022	0.05%	+0.01%	$488M	10.2M	+1,272,085	+14.3%	$47.95	Q4 2022
9/30/2022	0.02%	+0%	$214M	8.9M	+383,791	+4.51%	$24.00	Q3 2022
6/30/2022	0.02%	+0%	$185M	8.51M	+136,464	+1.63%	$21.76	Q2 2022
3/31/2022	0.02%	+0%	$202M	8.38M	+502,592	+6.38%	$24.15	Q1 2022
12/31/2021	0.01%	+0%	$187M	7.87M	+45,965	+0.59%	$23.79	Q4 2021
9/30/2021	0.02%	+0%	$199M	7.83M	+121,577	+1.58%	$25.37	Q3 2021
6/30/2021	0.01%		$173M	7.71M			$22.51	Q2 2021
3/31/2021	0.01%		$152M	7.7M			$19.75^*	Q1 2021
12/31/2020	0.02%	+0%	$203M	7.64M	+1,266,642	+19.9%	$26.57	Q4 2020
9/30/2020	0.03%	+0.01%	$315M	6.38M	+1,669,004	+35.5%	$49.38	Q3 2020
6/30/2020	0.02%	+0.02%	$149M	4.71M	+4,706,759	NEW	$31.61	Q2 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.